PreveCeutical Medical Inc
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddict… Read more
Market Cap & Net Worth: PreveCeutical Medical Inc (PRVCF)
PreveCeutical Medical Inc (OTCQB:PRVCF) has a market capitalization of $7.80 Million ($7.80 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #30684 globally and #10104 in its home market, demonstrating a -16.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PreveCeutical Medical Inc's stock price $0.01 by its total outstanding shares 586811959 (586.81 Million).
PreveCeutical Medical Inc Market Cap History: 2017 to 2025
PreveCeutical Medical Inc's market capitalization history from 2017 to 2025. Data shows change from $64.55 Million to $7.80 Million (-24.96% CAGR).
PreveCeutical Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PreveCeutical Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1936.03x
PreveCeutical Medical Inc's market cap is 1936.03 times its annual revenue
1728.56x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $64.55 Million | $22.23K | -$7.23 Million | 2903.18x | N/A |
| 2018 | $19.83 Million | $15.45K | -$11.88 Million | 1283.60x | N/A |
| 2019 | $5.87 Million | $3.03K | -$3.58 Million | 1936.03x | N/A |
Competitor Companies of PRVCF by Market Capitalization
Companies near PreveCeutical Medical Inc in the global market cap rankings as of March 18, 2026.
Key companies related to PreveCeutical Medical Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
PreveCeutical Medical Inc Historical Marketcap From 2017 to 2025
Between 2017 and today, PreveCeutical Medical Inc's market cap moved from $64.55 Million to $ 7.80 Million, with a yearly change of -24.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $7.80 Million | -7.64% |
| 2024 | $8.45 Million | -20.44% |
| 2023 | $10.62 Million | +1.12% |
| 2022 | $10.50 Million | +13.29% |
| 2021 | $9.27 Million | -32.77% |
| 2020 | $13.79 Million | +135.00% |
| 2019 | $5.87 Million | -70.41% |
| 2018 | $19.83 Million | -69.27% |
| 2017 | $64.55 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PreveCeutical Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.80 Million USD |
| MoneyControl | $7.80 Million USD |
| MarketWatch | $7.80 Million USD |
| marketcap.company | $7.80 Million USD |
| Reuters | $7.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.